Shareholder Alert: The Ademi Firm investigates whether ProAssurance Corporation is obtaining a Fair Price for its Public Shareholders

Core Viewpoint - ProAssurance is under investigation for potential breaches of fiduciary duty related to its transaction with The Doctors Company, which involves a cash payment of $25.00 per share, totaling approximately $1.3 billion [1][2]. Group 1: Transaction Details - ProAssurance shareholders will receive $25.00 in cash per share, with the total transaction value estimated at $1.3 billion [2]. - The transaction agreement includes provisions that significantly limit competing offers for ProAssurance, imposing penalties if a competing bid is accepted [3]. Group 2: Investigation Focus - The investigation is centered on the conduct of ProAssurance's board of directors and whether they are adequately fulfilling their fiduciary duties to all shareholders [3].